Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
Jennemann R, Volz M, Frias-Soler R, Schulze A, Richter K, Kaden S
Int J Mol Sci. 2025; 26(1.
PMID: 39796160
PMC: 11720485.
DOI: 10.3390/ijms26010304.
Rasheed H, Deng B, Ahmad D, Bao J
Int J Mol Sci. 2024; 25(23).
PMID: 39684503
PMC: 11640895.
DOI: 10.3390/ijms252312795.
Malarz K, Ziola P, Zych D, Rurka P, Mrozek-Wilczkiewicz A
Sci Rep. 2024; 14(1):26951.
PMID: 39505960
PMC: 11541782.
DOI: 10.1038/s41598-024-77575-4.
Baeza-Morales A, Medina-Garcia M, Martinez-Peinado P, Pascual-Garcia S, Pujalte-Satorre C, Lopez-Jaen A
Antioxidants (Basel). 2024; 13(9).
PMID: 39334719
PMC: 11428676.
DOI: 10.3390/antiox13091060.
Uterine cyclin A2-deficient mice as a model of female early pregnancy loss.
Aljubran F, Schumacher K, Graham A, Gunewardena S, Marsh C, Lydic M
J Clin Invest. 2024; 134(22).
PMID: 39264721
PMC: 11563677.
DOI: 10.1172/JCI163796.
NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle .
Wu P, Zhao L, Zhang H, Lou Y, Chen D, Xue S
Oncol Res. 2024; 32(9):1439-1452.
PMID: 39220139
PMC: 11361896.
DOI: 10.32604/or.2024.047490.
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells.
Carvalho M, Calicchio C, de Almeida B, de Miranda L, Lipreri da Silva J, Lima K
Clinics (Sao Paulo). 2024; 79:100422.
PMID: 38972247
PMC: 11276928.
DOI: 10.1016/j.clinsp.2024.100422.
A black phosphorus nanosheet-based RNA delivery system for prostate cancer therapy by increasing the expression level of tumor suppressor gene PTEN via CeRNA mechanism.
Su S, Liu L, Fu Q, Ma M, Yang N, Pan T
J Nanobiotechnology. 2024; 22(1):391.
PMID: 38965509
PMC: 11223337.
DOI: 10.1186/s12951-024-02659-2.
Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation.
Gu J, Zhang S, Lin D, Wang W, Cheng J, Zheng Q
Cell Oncol (Dordr). 2024; 48(1):67-81.
PMID: 38954215
PMC: 11850494.
DOI: 10.1007/s13402-024-00956-4.
Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR.
Shatat A, Mahgoup E, Rashed M, Saleh I, Akool E
Purinergic Signal. 2024; 20(6):669-680.
PMID: 38801618
PMC: 11554961.
DOI: 10.1007/s11302-024-10021-2.
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung T, Ngamjarus C, Proungvitaya T, Saengboonmee C, Proungvitaya S
PLoS One. 2024; 19(5):e0303337.
PMID: 38758750
PMC: 11101050.
DOI: 10.1371/journal.pone.0303337.
Mitotic Functions and Characters of KIF11 in Cancers.
Gao W, Lu J, Yang Z, Li E, Cao Y, Xie L
Biomolecules. 2024; 14(4).
PMID: 38672404
PMC: 11047945.
DOI: 10.3390/biom14040386.
Multiple functions of the nonstructural protein 3D in picornavirus infection.
Xu C, Wang M, Cheng A, Yang Q, Huang J, Ou X
Front Immunol. 2024; 15:1365521.
PMID: 38629064
PMC: 11018997.
DOI: 10.3389/fimmu.2024.1365521.
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs.
Advani D, Kumar P
Mol Neurobiol. 2024; 61(11):8600-8630.
PMID: 38532240
DOI: 10.1007/s12035-024-04130-7.
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Rossini E, Tamburello M, Abate A, Zini S, Ribaudo G, Gianoncelli A
Cells. 2024; 13(5.
PMID: 38474332
PMC: 10931172.
DOI: 10.3390/cells13050368.
Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis.
Li S, Li T, Shi Y, Xu B, Deng Y, Sun X
Cancer Biomark. 2024; 40(1):27-45.
PMID: 38393891
PMC: 11191499.
DOI: 10.3233/CBM-230113.
Coordination of cell cycle and morphogenesis during organ formation.
Matthew J, Vishwakarma V, Le T, Agsunod R, Chung S
Elife. 2024; 13.
PMID: 38275142
PMC: 10869137.
DOI: 10.7554/eLife.95830.
Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer.
Mollanoori H, Ghelmani Y, Hassani B, Dehghani M
Sci Rep. 2024; 14(1):91.
PMID: 38167453
PMC: 10761719.
DOI: 10.1038/s41598-023-50230-0.
Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.
Kasprzak A
Cancers (Basel). 2023; 15(18).
PMID: 37760539
PMC: 10526446.
DOI: 10.3390/cancers15184570.